A Phase II Randomized Trial of Fish Oil in Patients With Acute Lung Injury (ALI)

NCT00351533 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Respiratory Distress Syndrome, Adult
Acute Lung Injury
Acute Respiratory Distress Syndrome

Interventions

DRUG: Fish oil (eicosapentaenoic acid and docosahexanoic acid)

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]